We are live on ! Find out more
SCM

SCS Capital Management Portfolio holdings

AUM $9.44B
1-Year Est. Return 18.1%
This Fund
S&P 500
This Quarter Est. Return
+9.2%
1 Year Est. Return
+18.1%
3 Year Est. Return
+43.85%
5 Year Est. Return
+38.42%
10 Year Est. Return
+105.54%
AUM
$9.02B
AUM Growth
+$1.16B
Cap. Flow
+$465M
Cap. Flow %
5.16%
Top 10 Hldgs %
50.19%
Holding
567
New
54
Increased
230
Reduced
170
Closed
18

Top Buys

Rank Stock Value
1
QUAL icon
iShares MSCI USA Quality Factor ETF
QUAL
+$57.7M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$39.8M
3
MSFT icon
Microsoft
MSFT
+$21.9M
4
RTX icon
RTX Corp
RTX
+$19.9M
5
JPM icon
JPMorgan Chase
JPM
+$18.7M

Top Sells

Rank Stock Value
1
COWZ icon
Pacer US Cash Cows 100 ETF
COWZ
+$23.6M
2
LPLA icon
LPL Financial
LPLA
+$19.7M
3
XPEL icon
XPEL
XPEL
+$16.8M
4
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$14.8M
5
VIGI icon
Vanguard International Dividend Appreciation ETF
VIGI
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 3.46%
2 Financials 3.09%
3 Healthcare 2.24%
4 Industrials 1.55%
5 Consumer Discretionary 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSM icon
551
Black Stone Minerals
BSM
$3.17B
– –
-14,310
Closed -$219K
CFR icon
552
Cullen/Frost Bankers
CFR
$10.4B
– –
-1,637
Closed -$205K
DFS
553
DELISTED
Discover Financial Services
DFS
– –
-3,311
Closed -$565K
FICO icon
554
Fair Isaac
FICO
$23.5B
– –
-169
Closed -$312K
IGV icon
555
iShares Expanded Tech-Software Sector ETF
IGV
$14.3B
– –
-7,553
Closed -$672K
IXN icon
556
iShares Global Tech ETF
IXN
$8.8B
– –
-4,032
Closed -$305K
MGM icon
557
MGM Resorts International
MGM
$11.5B
– –
-10,952
Closed -$325K
NVTS icon
558
Navitas Semiconductor
NVTS
$3.26B
– –
-276,595
Closed -$567K
OPEN icon
559
Opendoor
OPEN
$3.66B
– –
-55,693
Closed -$55K
SCHA icon
560
Schwab U.S Small- Cap ETF
SCHA
$23.1B
– –
-18,585
Closed -$435K
SLB icon
561
SLB Ltd
SLB
$74.5B
– –
-9,444
Closed -$398K
SPYI icon
562
NEOS S&P 500 High Income ETF
SPYI
$11.2B
– –
-58,986
Closed -$2.82M
TSVT
563
DELISTED
2seventy bio
TSVT
– –
-41,392
Closed -$204K
TTE icon
564
TotalEnergies
TTE
$189B
– –
-3,957
Closed -$257K
VLN icon
565
Valens Semiconductor
VLN
$181M
– –
-11,492
Closed -$23.4K
VRTX icon
566
Vertex Pharmaceuticals
VRTX
$122B
– –
-416
Closed -$202K
ITCI
567
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-72,743
Closed -$9.6M
19 20 21 22
23

Similar funds

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
BAMF
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $9.55B AUM 31.94% 1-Year Est. Return

SCS Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, SCS Capital Management held 567 positions worth $9.02B, up 15% from $7.86B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

SCS Capital Management deployed $465M of net new capital in Q2 2025, opening 54 new positions and adding to 230 existing holdings. Its largest new stake was Ventas: 216,900 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 3.5% of assets, up from 2.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Pacer US Cash Cows 100 ETF, an estimated $23.6M trimmed.

  • SCS Capital Management's largest Q2 2025 buy was Ventas: 216,900 shares worth $13.8M.
  • SCS Capital Management added most to iShares MSCI USA Quality Factor ETF in Q2 2025, an estimated $57.7M increase.
  • SCS Capital Management's biggest Q2 2025 reduction was Pacer US Cash Cows 100 ETF, cutting an estimated $23.6M.
  • SCS Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $9.6M.
  • SCS Capital Management's ten largest holdings make up 50% of its $9.02B portfolio in Q2 2025.
  • SCS Capital Management opened 54 new positions and closed 18 in Q2 2025.
  • SCS Capital Management's portfolio value rose 15% quarter-over-quarter to $9.02B.

Based on SCS Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.